The Impact of bilateral endoscopic thoracic sympathectomy on hyperhidrosis patients’ quality of life and its link to psychiatric disorders

Abstract

Background and Aims: To measure the Quality of Life (QOL) of patients with hyperhidrosis after undergoing Bilateral en¬doscopic thoracic sympathectomy (BETS), and its association with psychiatric disorders, that were diagnosed using MINI psychiatric interview, and compensatory hyperhidrosis (CH). Methods: A retrospective cross-sectional study was carried out on patients with primary hyperhidrosis after undergoing BETS. 50 Patients were recruited from King Saud University Medical City database and contacted via phone calls. The interview contained a hyperhidrosis-specific QOL questionnaire, and a diagnostic psychiatric questionnaire MINI. The QOL results were classified into 5 categories and used to study QOL and its associated factors. Results: The reported QOL before the operation has 52% of the patients showing negative QOL. Alternately, the reported QOL after the operation improved with 96% patients showing positive QOL. Among this sample, 76% reported suffering from CH post procedure, 28% were diagnosed with one or more mood disorders, and 20% were diagnosed with one or more anxiety disorders. No statistical relationship was found linking the QOL of the sample to the occurrence of CH or the presence of any common psychiatric disorder. Conclusions: In conclusion, there was a significant improvement in the patients’ QOL after BETS. The improvement in QOL was unaffected by the surgeries most notable complication, compensatory hyperhidro¬sis, or the presence of any common psychiatric disorder that they were diagnosed with post-surgery. Further research is needed to explore factors that may affect the QOL of these patients.

References

1. 1.Kristensen JK, Nielsen C. Progress and lack of progress in hyperhidrosis research 2015-2020. A concise systematic review. Int J Dermatol. 2022;61(2):148–57.
2. 2.Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review: Etiology and clinical work-up. J Am Acad Dermatol. 2019;81(3):657–66.
3. 3.Dharmaraj B, Kosai NR, Gendeh H, Ramzisham AR, Das S. A Prospective cohort study on quality of life after endoscopic thoracic sympathectomy for primary hyperhidrosis. Clin Ter. 2016 May 1;167(3):67-71.
4. 4.Kamudoni P, Mueller B, Halford J, SchouvellerA,StaceyB,SalekMS.The impact of hyperhidrosis on patients’ daily life and quality of life: a qualitative investigation. Health and quality of life outcomes. 2017 Dec;15:1-0.
5. 5.Glaser DA, Hebert A, Pieretti L, Pariser D. Understanding Patient Experience With Hyperhidrosis: A National Survey of 1,985 Patients. Journal of Drugs in Dermatology: JDD. 2018Apr 1;17(4):392-6.
6. 6.Shayesteh A, Boman J, Janlert U, Brulin C, Nylander E. Primary hyperhidrosis: implications on symptoms, daily life, health and alcohol consumption when treated with botulinum toxin. The Journal of Dermatology. 2016 Aug;43(8):928-33.
7. 7.Bahar R, Zhou P, LiuY, HuangY, Phillips A, Lee TK, Su M, Yang S, Kalia S, Zhang X, ZhouY. The prevalence of anxiety and depression in patients with 16 Majmaah Journal of Health Sciences ,Vol. 12, Issue 2 , April - 2024, Shawwal - 1445 The Impact of bilateral endoscopic thoracic sympathectomy on hyperhidrosis patients’quality of life and its link to psychiatric disorders or without hyperhidrosis HH. Journal of the American Academy of Dermatology. 2016 Dec 1;75(6):1126-33
8. 8.Gross KM, Schote AB, Schneider KK, Schulz A, Meyer J. Elevated social stress levels and depressive symptoms in primary hyperhidrosis. PLoS One. 2014 Mar 19;9(3):e92412.
9. 9.Klein SZ, Hull M, Gillard KK, Peterson-Brandt J. Treatment patterns, depression, and anxiety among US patients diagnosed with hyperhidrosis: a retrospective cohort study. Dermatology and Therapy. 2020 Dec;10:1299-
10. 10.26.Brackenrich J, Fagg C. Hyperhidrosis. StatPearls Publishing; 2022